前收市價 | 0.7500 |
開市 | 1.0000 |
買盤 | 0.8000 |
賣出價 | 4.0000 |
拍板 | 7.50 |
到期日 | 2024-06-21 |
今日波幅 | 1.0000 - 1.0000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 928 |
Data from a late-stage study shows that transfusion-dependent thalassemia patients who received Agios' (AGIO) Pyrukynd demonstrated a statistically significant reduction in transfusion burden.
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.